Open original FDA record ↗Recall record
- FDA identifier
- Z-0355-2024
- Company in FDA record
- B. Braun Medical, Inc.
- FDA classification date
- Dec 1, 2023
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
In affected products, the tubing outer diameter may vary in size or the length of tubing may be too short. Both issues may lead to false air-in-line alarms, which will stop the infusion and interrupt therapy. Interruptions or delays in medication administration may result in serious injury to patients which may be life-threatening (e.g. interruption of a vasopressor to a hemodynamically unstable patient) or may lead to death.
Source facts
- Action
- On November 1, 2023, the firm notified customers via URGENT MEDICAL DEVICE CORRECTION letters. Customers were informed that administration sets with lot number 0061902124 and higher were manufactured with revised specifications which should reduce the potential for false air-in-line alarms. After November 30, 2023, all lots distributed by BBMI will have been manufactured with these revised specifications. The firm provided interim measures for users to apply for affected product. For example, users should not use tubing with noticeably smaller outer diameter or which needs to be stretched to fit within the pump. If possible, unaffected lots of product should be diverted to areas that infuse high risk medications or other infusions with acute clinical effects due to initial limited supply of the new administration sets. Affected lots should be diverted to care areas that do not infuse high risk medications or other infusions with acute clinical effects. When infusing high risk medications or infusions with acute clinical effects, customers were advised to have a second pump with an administration set available for exchange in the event of a false alarm. If a second pump is not available, have a second administration set available for exchange in the event of a a false alarm. Additional patient monitoring is required. Adverse reactions or quality problems experienced with this product, or questions about this correction may be reported to BBMI s Postmarket Surveillance Department by calling 1-833-425-1464.
- Initiated
- 2023-11-01
- Root cause
- Process control
- Distribution
- Distribution US nationwide, Canada and Germany.
- Recall number
- Z-0355-2024
- Recall status
- Open, Classified
- CDRH record ID
- 203733
- FDA classified
- 2023-12-01
- Recall event number
- 93232